Document is current
Any future updates will be listed below
-
Authors
Palencia-Campos, Adrián
Ruiz-Cañas, Laura
Abal-Sanisidro, Marcelina
López-Gil, Juan Carlos
Batres-Ramos, Sandra
Saraiva, Sofia Mendes
Yagüe, Balbino
Navarro, Diego
Alcalá, Sonia
Rubiolo, Juan A.
Bidan, Nadège
Sánchez, Laura
Mura, Simona
Hermann, Patrick C.
de la Fuente, María
Sainz, Bruno
-
Funding
Funding for this research was provided by:
Juan de la Cierva Formación Fellowship (FJC2020-044220-I)
IDIS Predoctoral Fellowship
'la Caixa' Foundation (LCF/BQ/DR21/11880011)
EMBO Scientific Exchange Fellowship (10210)
Max Eder Fellowship of the German Cancer Aid (111746)
Instituto de Salud Carlos III (AC18/00107)
ERA-NET EURONANOMED III (JTC2018/041, JTC2018/041)
MICIU Joint Transnational Call for Proposals/PCI 2019-1 (PCI2019-103725)
FIS (PI18/00757)
European Regional Development Fund (“Una manera de hacer Europa”)
Fundación Asociación Española Contra el Cáncer (GC16173694BARB)
Consejo Superior de Investigaciones Cientificas
- License Information
-
More Information
Article History
Received: 15 May 2024
Accepted: 12 November 2024
First Online: 24 December 2024
Declarations
:
: All in vivo procedures in mice were conducted in accordance with protocols approved by the local Animal Experimental Ethics Committee of the Instituto de Salud Carlos III (PA 34–2012) or the Use Committee for Animal Care from the Universidad Autónoma de Madrid (UAM) (Ref# CEI-25–587) and the Comunidad de Madrid (PROEX 335/14 or 294/19).
: All authors agree with the publication
: The authors declare the following competing financial interest(s): M.d.l.F. is the co-founder and CEO of DIVERSA Technologies SL. The remaining authors declare no competing of interest.
